Jing-Yan Han Selected Research

Eosine Yellowish-(YS) (Eosin)

1/2019	A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
2/2014	Ginsenoside Rb1 ameliorates lipopolysaccharide-induced albumin leakage from rat mesenteric venules by intervening in both trans- and paracellular pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing-Yan Han Research Topics

Disease

29	Ischemia 01/2024 - 01/2005
14	Edema (Dropsy) 06/2022 - 04/2012
10	Reperfusion Injury 01/2021 - 08/2009
8	Infarction (Infarctions) 01/2024 - 04/2010
8	Fibrosis (Cirrhosis) 11/2022 - 01/2012
7	Inflammation (Inflammations) 05/2024 - 05/2013
7	Hemorrhage 01/2024 - 03/2015
6	Cerebral Infarction 01/2024 - 01/2005
6	Myocardial Infarction 12/2023 - 04/2010
6	Neoplasms (Cancer) 12/2023 - 08/2013
6	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2012
6	Brain Edema (Cerebral Edema) 01/2021 - 04/2012
5	Lung Injury 05/2024 - 03/2013
5	Ischemic Stroke 01/2021 - 10/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2010
5	Coronary Disease (Coronary Heart Disease) 03/2019 - 01/2005
5	Thrombosis (Thrombus) 01/2018 - 01/2006
4	Body Weight (Weight, Body) 01/2022 - 01/2012
3	Colitis 01/2024 - 01/2013
3	Cerebral Hemorrhage 01/2024 - 01/2018
3	Stroke (Strokes) 01/2024 - 01/2020
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 10/2014
3	Hypoxia (Hypoxemia) 01/2022 - 01/2018
3	Rupture 01/2021 - 09/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 01/2018
3	Fatty Liver 08/2017 - 12/2009
3	Non-alcoholic Fatty Liver Disease 08/2017 - 06/2013
3	Vascular Diseases (Vascular Disease) 12/2009 - 01/2005
2	Infections 05/2024 - 06/2022
2	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2019
2	Endotoxemia 01/2019 - 10/2013
2	Atherosclerosis 01/2019 - 01/2005
2	Hypertrophy 01/2019 - 01/2016
2	Cognitive Dysfunction 01/2018 - 01/2018
2	Necrosis 01/2018 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2008
2	Acute Lung Injury 12/2016 - 11/2014
2	Hypertension (High Blood Pressure) 01/2016 - 01/2013
2	Brain Ischemia (Cerebral Ischemia) 06/2015 - 10/2012

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2010
15	AlbuminsIBA 01/2024 - 04/2012
12	qishen yiqiIBA 01/2022 - 01/2012
11	Evans Blue (Blue, Evans)FDA Link 01/2024 - 04/2012
9	Adenosine Triphosphate (ATP)IBA 12/2023 - 01/2013
8	CytokinesIBA 05/2024 - 10/2014
8	Cardiotonic Agents (Cardiac Stimulants)IBA 11/2022 - 01/2005
6	Claudin-5IBA 01/2024 - 10/2012
6	AntioxidantsIBA 01/2019 - 01/2009
6	CollagenIBA 01/2019 - 01/2012
5	OccludinIBA 01/2024 - 10/2012
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2009
5	LipopolysaccharidesIBA 06/2020 - 02/2014
5	Adenosine Monophosphate (AMP)IBA 01/2018 - 01/2013
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 01/2018
4	astragaloside AIBA 06/2022 - 11/2013
4	notoginsenoside R1IBA 01/2021 - 01/2008
4	Adenosine Diphosphate (ADP)IBA 01/2018 - 09/2013
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 01/2013
3	Interleukin-6 (Interleukin 6)IBA 05/2024 - 01/2019
3	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 01/2019
3	Small Interfering RNA (siRNA)IBA 06/2022 - 08/2013
3	cadherin 5IBA 01/2022 - 01/2017
3	Caveolin 1IBA 01/2021 - 10/2012
3	SirtuinsIBA 01/2021 - 08/2015
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 03/2015
3	gualou xiebai baijiutangIBA 03/2019 - 01/2018
3	Sirtuin 3IBA 01/2019 - 08/2015
3	salvianolic acidIBA 01/2019 - 11/2010
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2013
3	Insulin (Novolin)FDA Link 01/2019 - 01/2015
3	src-Family KinasesIBA 01/2018 - 06/2015
3	caffeic acidIBA 09/2015 - 04/2012
2	ferric chlorideIBA 01/2024 - 01/2021
2	CateninsIBA 01/2024 - 01/2022
2	ImmunosorbentsIBA 10/2023 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023 - 01/2019
2	EnzymesIBA 10/2023 - 01/2019
2	Actins (F Actin)IBA 01/2021 - 01/2018
2	yi-qi-fu-maiIBA 01/2021 - 09/2009
2	Connexin 43 (Connexin43)IBA 01/2021 - 01/2019
2	Thrombin FDA Link 01/2020 - 01/2018
2	Therapeutic UsesIBA 02/2019 - 10/2012
2	oxidized low density lipoproteinIBA 01/2019 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 08/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 02/2014
2	Hematoxylin (Haematoxylon)IBA 01/2019 - 02/2014
2	Laminin (Merosin)IBA 01/2018 - 12/2016
2	Silybin (Lagosa)IBA 01/2018 - 08/2017
2	sym-trinitrobenzeneIBA 01/2017 - 01/2013
2	Sulfonic AcidsIBA 01/2017 - 01/2013
2	Tight Junction ProteinsIBA 01/2017 - 10/2012
2	Coloring Agents (Dyes)IBA 06/2013 - 04/2012
2	salvianolic acid BIBA 03/2013 - 01/2009
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2013 - 04/2010
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 04/2010
2	Caspase 3 (Caspase-3)IBA 04/2012 - 04/2010

Therapy/Procedure

11	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2008
9	Therapeutics 01/2024 - 10/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
2	Lasers (Laser) 01/2013 - 01/2012